Strategic & Transformational Modeling

We combine advanced analytics, economic rigor and sector expertise to guide healthcare and life sciences organizations through high-stakes strategic decisions. Our economists assess demand, optimize assets, evaluate technology, service and regulatory changes, and proposed transformational changes and investments including in agency reviews. We provide evidence-based market sizing, profitability and value-prop analysis, and population-health insights that strengthen M&A, private equity diligence and transformation.

Because providers, insurers and governments operate in a dynamic healthcare environment, simple trend extrapolation may not suffice for sound predictions. The Center’s microsimulation models are appropriately detailed for economically sound estimates — able to assess transformational change initiatives while explicitly accounting for changes in population, diversity and economic growth. Our advanced modelling capabilities extend to predictive modelling of current and future impact of proposed investments or expansion in substantial new facilities or services on costs, access, quality or services for comprehensive assessments in state or federal agencies in regulatory reviews or for strategic choices and decision-making by health systems. To help assess the impact of significant potential changes in policy and regulation, and ongoing major changes in healthcare delivery and demand for stakeholders across the healthcare continuum, Center economists have developed advanced models of hospital finances, risk, and impact in market environments strengthened in partnership with FTI’s multi-disciplinary teams.

Click here to download the full service sheet